Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rufinamide 100mg tablets
0408010AFAAAAAA
|
Rufinamide | Rufinamide | Central Nervous System | 594 |
|
Oxycodone 10mg tablets
0407020ADAAAUAU
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 592 |
|
Luventa XL 8mg capsules
0411000F0BJAAAE
|
Luventa XL | Galantamine | Central Nervous System | 591 |
|
Ondansetron 8mg orodispersible films sugar free
0406000S0AAANAN
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 586 |
|
Calpol Six Plus 250mg/5ml oral suspension sugar free
0407010H0BEAMBG
|
Calpol | Paracetamol | Central Nervous System | 584 |
|
ReQuip 1mg tablets
0409010H0BBABAB
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 584 |
|
Isocarboxazid 10mg tablets
0403020H0AAAAAA
|
Isocarboxazid | Isocarboxazid | Central Nervous System | 582 |
|
Zopiclone 3.75mg/5ml oral solution
0401010Z0AAAJAJ
|
Zopiclone | Zopiclone | Central Nervous System | 582 |
|
MXL 30mg capsules
0407020Q0BIAAEG
|
MXL | Morphine sulfate | Central Nervous System | 581 |
|
Sodium valproate 100mg MR gran sachets sugar free
0408010W0AABWBW
|
Sodium valproate | Sodium valproate | Central Nervous System | 581 |
|
Pipexus 2.62mg modified-release tablets
0409010W0BEAFAK
|
Pipexus | Pramipexole | Central Nervous System | 580 |
|
Mintreleq XL 400mg tablets
0402010ABBJAEAY
|
Mintreleq XL | Quetiapine | Central Nervous System | 577 |
|
Zyprexa 2.5mg tablets
040201060BBADAD
|
Zyprexa | Olanzapine | Central Nervous System | 570 |
|
Briviact 100mg tablets
0408010ALBBAEAE
|
Briviact | Brivaracetam | Central Nervous System | 564 |
|
Chlorpromazine 100mg/5ml oral solution
0402010D0AAAFAF
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | 564 |
|
MigraMax oral powder sachets
0407041A0BIAAAJ
|
MigraMax | Analgesics with anti-emetics | Central Nervous System | 563 |
|
Abstral 200microgram sublingual tablets
0407020A0BJABAX
|
Abstral | Fentanyl | Central Nervous System | 561 |
|
Cytisinicline 1.5mg tablets
0410020E0AAAAAA
|
Cytisinicline | Cytisinicline | Central Nervous System | 561 |
|
Seroquel XL 400mg tablets
0402010ABBBAKAY
|
Seroquel | Quetiapine | Central Nervous System | 561 |
|
Risperidone 50mg inj vials
0402020AAAAABAB
|
Risperidone (Parenteral) | Risperidone | Central Nervous System | 559 |
|
Campral EC 333mg tablets
0410010A0BBAAAA
|
Campral | Acamprosate calcium | Central Nervous System | 555 |
|
Tramadol 400mg modified-release tablets
040702040AAANAN
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | 555 |
|
Maxitram SR 150mg capsules
040702040BPACAI
|
Maxitram | Tramadol hydrochloride | Central Nervous System | 552 |
|
Mintreleq XL 150mg tablets
0402010ABBJABBA
|
Mintreleq XL | Quetiapine | Central Nervous System | 550 |
|
Paracetamol 500mg / Metoclopramide 5mg efferv pdr sach SF
0407041A0AAACAC
|
Analgesics with anti-emetics | Analgesics with anti-emetics | Central Nervous System | 548 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.